comparemela.com

Latest Breaking News On - Monaco asset management - Page 6 : comparemela.com

Jasper Therapeutics, Inc (NASDAQ:JSPR) Receives $64 17 Average PT from Brokerages

Jasper Therapeutics, Inc (NASDAQ:JSPR) Receives $64 17 Average PT from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Short Interest in Fate Therapeutics, Inc (NASDAQ:FATE) Grows By 14 7%

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 18,920,000 shares, an increase of 14.7% from the March 31st total of 16,490,000 shares. Based on an average daily volume of 2,780,000 shares, […]

Capital One Financial Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)

Capital One Financial started coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $6.00 price objective on the biotechnology company’s stock. Capital One Financial also issued estimates for Heron Therapeutics’ Q1 2024 earnings at […]

Heron Therapeutics (NASDAQ:HRTX) Earns Overweight Rating from Analysts at Capital One Financial

Heron Therapeutics (NASDAQ:HRTX) Earns Overweight Rating from Analysts at Capital One Financial
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

PSI Advisors LLC Has $51,000 Position in Esperion Therapeutics, Inc (NASDAQ:ESPR)

PSI Advisors LLC lifted its stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 161.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,500 shares during the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.